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Abstract
Objective: Sub-Saharan A frica has the h ighest num ber o f  H iy /A ID S  cases g lobally  w hich contrasts w ith the 
lack o f  population-based studies o f  oral K aposi's sarcom a (OKS); one o f  the clinical cardinal signs o f  
HIV/AID S. To date, no study has investigated the incidence o f  OKS in A frican populations affected by the 
H IV/AID S epidem ic. It is, therefore, the purpose o f  this study to assess the burden o f  OKS in the Zim babw ean 
population over a 10 year period.
Design: A  descriptive epidem iological study w as undertaken to assess the burden o f  O K S by  determ ining the 
frequencies, incidence and cum ulative rates, the lifetim e risk  and chances o f  developing OK S according to 
site (topography), gender, age, race/ethnic origin o f  the Z im babw ean population. A  total o f  445 incident 
cases o f  OKS from  the upper and low er lips, oral vestibule, retrom olar area, floor o f  m outh, tongue, cheek, 
m ucosa, gum s, hard  and soft palate w ere accessed from  the Z im babw e N ational C ancer Registry (ZNCR). 
Cases from  the skin, pharynx, larynx and the m ajor salivary glands w ere excluded from  the study.
Setting: This com prised the population  o f  Z im babw e during the 10 year period  1988-1997. The population 
figures used for this study w ere fro the 1992 Census Z im babw e N ational Report. The study population w as 
standardized by  the direct m ethod against the w orld standard population to calculate the age standardized 
incidence rate (A SIR). The SP S S  statistical softw are program m e (SPSS Inc. 2001, U SA ) w as used  for the 
statistical analysis.
Results: O K S com prised 0.92%  o f  to tal body m alignancies and 51 %  o f  oral m alignancies w ith  a  m ean age o f  
study cases o f  37.6 years and m edian age o f  32 years. H istology o f  the prim ary (64.5% ) and clinical diagnosis 
(34.6% ) w ere the predom inant m ethods o f  diagnosis. OKS affected nearly  only  blacks and m ales m ore than 
fem ales, w ith a m ale to fem ale ratio  o f  1.9:1. The m ost affected age groups by  OK S w ere the 30 to 34 years for 
m ale and 25 to 29 years for both fem ales and the w hole population. O ther notable peaks in OK S rates w ere in 
the 0 to 4  year and the 75+ age groups. O K S m ostly  affected the palate (70.2% ) follow ed by, in descending 
order, the tongue (13.3% ) and m outh  (8.3% ). The age adjusted age standardized incidence rate (ASIR) o f  
OKS exponentially increased the entire study period bypassing oral squam ous cell carcinom a (O SCC) as the 
predom inant oral m alignancy in 1994. A m ong A ID S-associated m alignancies, OKS accounted for 98%  
w hile the balance com prised B urkitt's  lym phom a, H odgkin 's and N on-H odgkin 's lym phom as,
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haem angiosarcom a and lym phom a not specified.
Conclusion: OKS w as the com m onest m alignancy o f  young adults affecting m ales m ore than fem ales. OKS 
steady increased for the entire study period overtaking SCC in 1994 to becom e the com m onest oral 
m alignancy for the rem ainder o f  the study period. The palate w as the m ost affected intra-oral site by OKS. 
These findings are attributable to  the high hum an im m unodeficiency virus infection (H IV ) rates recorded for
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Introduction
Studies from Uganda, Rwanda and Zimbabwe have 
reported sharp increases in the incidence o f Kaposi's 
sarcoma (KS)1'5 which has become the most common 
malignancy associated with human immunodeficiency 
virus (HIV) infection and auto-immune deficiency 
syndrome (AIDS) epidemic1-2'6,7. Oral Kaposi's sarcoma 
(OKS) is one o f the seven cardinal lesions strongly 
associated with HIV infection and indicates HIV 
infection. OKS presents as one o f the early clinical 
features and is a marker o f HIY disease progression 
into full-blown AIDS" as well as being a prognostic 
marker during antiretroviral treatment (ART). Sub- 
Saharan Africa has the highest number o f HIV/AIDS 
cases globally which contrasts with the lack o f 
population-based studies on OKS; one o f the clinical 
cardinal signs o f HIV/AIDS. To date, no study has 
investigated the incidence o f oral KS (OKS) in African 
populations affected by the HIV/AIDS epidemic. It is, 
therefore, the purpose o f this study to assess the burden 
of OKS in the Zimbabwean population over a 10 year 
period.
M a te r ia ls  a n d  M ethods
The burden of oral Kaposi's sarcoma in Zimbabwe was 
assessed by determining the frequencies, incidence and 
cumulative rates, the lifetime risk and chances of 
developing OKS according to site (topography), 
gender, age and race/ethnic origin. During the study 
period, 1 January 1988 to 31 December 1997,445 case 
o f incident OKS out o f a total o f 873 oral malignancies 
and 47 906 cases of whole body malignancies were 
recorded by the Zimbabwe National Cancer Registry 
(ZNCR). The intra-oral sites investigated included, 
upper and lower lips; oral vestibule; retromolar area; 
floor of mouth; tongue; cheek, mucosa' gums; hard and 
soft palate. Cases from the skin, pharynx, larynx and 
the major salivary glands were excluded from the 
study. Distinction between lip vermilion and lip 
mucosal malignancies was not clarified in the original 
ZNCR data; hence the inclusion o f some lip vermilion 
KS among intra-oral KS was a distinct possibility. Oral 
squamous cell carcinoma (OSCC) is a common oral 
malignancy that was used to assess the relative rate of 
increase o f OKS. The accessed data for each case 
comprised information on age; gender; race; date of 
diagnosis; basis o f diagnosis and site/topogrr hy. 
Absolute anonymity o f identities o f patients whose 
case details comprised the raw data for this study was 
maintained throughout the study.
Population.
The population figures used for this study were from 
the 1992 Census Zimbabwe National Report. 
Zimbabwe had a total o f 10 412 548 persons 
comprising 5 083 537 males and 5 329011 females.12
Statistical M ethods.
The data was sorted into tables for males, females and 
the whole population in five year age groups against the 
site. The five year age groups and the upper limit o f 75+ 
were set for concordance with the 1992 Census 
population figures. Statistical analysis was done using 
the SPSS statistical software program (SPSS Inc. 2001, 
USA). The age specific incidence rate; crude rate; age 
standardized incidence rate (ASIR); cumulative rate; 
the cumulative (lifetime) risk and chances o f 
developing OKS were calculated using Microsoft 
Excel on Windows 98. The ASIR was age adjusted and 
standardized by the direct method against the world 
standard population. The cumulative rate was 
calculated using a defined life span o f 0 to 74 years. It 
follows, therefore, that the chances o f developing OKS 
that were calculated apply to the same life span o f 0 to 
74 years.
Results
OKS comprised 51 % o f oral malignancies and 0.92% 
of total body malignancies recorded during the study 
period. The mean age o f recorded patients was 37.6 
years while the median age was 32 years. The racial 
distribution was almost exclusively blacks as only one 
case was recorded in a 25 year old European female. 
Males bore the greater burden o f OKS with 65.6% of 
recorded cases and a male:female ratio of 1.9:1. The 
majority o f cases were diagnosed from the histology of 
the primary (64.5%) followed by clinically only 
(34.6%) while clinical, X-ray and ultra sound 
accounted for only 0.6%. Only one case o f metastatic 
KS (0.2%) was recorded in the oral cavity. OKS mostly 
affected the palate (70.2%) followed by, in descending 
order, the tongue (13.3%) and mouth (8.3%). 
Frequencies for the other oral sites are as shown in 
Table I.
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Table I: Site/topographical distribution o f  oral 
Kaposi’s sarcoma.
Table II: Rates, risks and chances o f  developing oral 
K aposi’s sarcoma among males, females and the whole 
population.
Site C ount Frequency
(% ) O ral K aposi’sarcom a (OKS)
External upper lip 2 ■ 0.4 Variable M ale Female Population
Mucosa o f upper lip 
Lip NOS
1 0.2
2 0.4
Tongue NOS 59 13.3 Age specific incidence 0.57 0.29 0.43
Gum NOS 16 3.7 rate (crude rate)/100 000
Floor of mouth NOS 1 0.2 pyrs
Hard palate 6 1.3
Soft palate 6 1.3 Age standardised 7.87 3.56 5.62
Palate NOS 312 70.2 incidence rate/100 000
Cheek mucosa 3 0.7 pyrs
Mouth NOS 37 8.3
Cumulative rate (%) 0.76 0.33 0.53
Total 4 4 5 100.0 Cumulative (lifetime) 
risk (%)
0.8 0.3 0.5
The most affected five year age groups by OKS were 
the 30 to 34 for males and 25 to 29 for both females and 
the whole population. Other notable peaks in OKS rates 
were in the 0 to 4 and the 75+ age groups. The ASIR of 
OKS increased steadily in all three population 
categories.
Figure I: Trends o f  OKS and OSCC fo r  the whole 
population by year ofstudy.
Year(19-)
A graphical plot o f the ASIRs o f OKS and OSCSS by 
year o f study in Figure I shows OKS steadily increasing 
for the entire study period overtaking SCC in 1994. 
Interestingly, the ASIR o f OSCC did not increase but 
stayed within a narrow range o f 0.6 to 1.0 per 100 000 
person years for eight o f the 10 years o f study. The 
crude rate, age adjusted ASIR, cumulative rate, the 
lifetime risk and the chances to develop OKS o f the 
study population are as given in Table II.
Chances of developing 1:132 1:299 1:188
OKS
The corresponding figures for OSCC were 0.32/100 
000 person years, 0.64/100 000 person years, 0.08% 
and 0.01% with one chance in 1 331 o f developing 
OSCC for the study population. Males had higher 
ASIR for OKS (7.87 per 100 000 person years) and 
OSCC (9.18 per 100 000 person years) than females 
with 3.56 and 3.69 person years respectively. Males 
had the highest ASIR for OSCC a decade earlier (50 to 
54 five year age group) than females (60 to 64 five year 
age group) as depicted in Figures II and III. Among 
AIDS-associated malignancies, OKS accounted for 
98% while the balance comprised Burkitt's lymphoma, 
H o d g k in 's  and N o n -H o d g k in 's  lym phom as, 
haemangiosarcoma and lymphoma not otherwise 
specified.
Figure II: Trends o f  OKS and OSCC amongfemales by 
five  year age groups.
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Figure II: Trends o f  OKS and OSCC among males by 
five  year age groups.
Discussion
This study was promoted by "a previous population- 
based study o f the burden o f oral malignancies in 
Zimbabwe where OKS was the commonest oral 
malignancy and mostly affected the palate.13 Previous 
studies from Zimbabwe6 '3 on general cancer trends 
have reported dramatic increases in the incidence of 
Kaposi's sarcoma (KS) making KS the most common 
cancer in males and the second most common in 
females after cervical cancer. In this study, the study 
population is seven times more likely to develop OKS 
than OSCC while males have double the chances of 
developing OKS compared to females. Consequently 
Kaposi's sarcoma has overtaken squamous cell 
carcinoma to become the most common form of oral 
maliganancy in the three population categories of 
males, females and the whole population during the 
study period. These changes were due to the HIV/AIDS 
epidemic in Zimbabwe where some of the highest HIV 
infection rates have been reported14 and non-provision 
of highly active antiretroviral therapy (HAART) in the 
public health sector during the study.
The frequency o f  o ther AIDS associa ted  
malignancies in this study is very low. This may either 
be due to occurrence o f the bulk o f such malignancies at 
extra-oral sites or death o f the patients before intra-oral 
involvement. It has been reported that survival o f cases 
with AIDS related KS is worse in younger than in older 
age groups and the median survival for AIDS patients 
presenting with KS is between 19 and 22 months.15 This 
could explain the low frequency o f other AIDS 
associated malignancies in this study as patients died 
before developing these malignancies. The non­
provision o f HAART during the study period at state 
hospitals in Zimbabwe worsened the prognosis o f 
patients with KS.
The role of y  herpes virus, human herpes virus 8 
(HHV-8), in the pathogenesis o f  KS presents 
conflicting views. There is a widely held view that 
HHV-8 plays a synergistic role in the pathogenesis c? 
KS1519. HIV-1 is the most prevalent HIV strain in 
Zimbabwe.13 However, evidence from Ivory Coast in
West Africa prompts a revision o f this view. A study 
from Ivory Coast reported high ant-HHV-8 antibodies 
comparable to complication of HIV-2 infection than it 
was o f HIV-1 infection.21 The same authors also 
reported that increases in infection rates since 1987 had 
been largely due to the transmission o f HIV-1, whereas 
the infection rates o f HIV-2 had remained stable or had 
declined. Furthermore, the same group o f authors 
found that prior to the AIDS epidemic, KS was a 
relatively rare cancer in West Africa compared with the 
endemic areas in east and southern Africa. In their 
opinion, this did not appear to reflect a marked 
difference in the prevalence o f infection with the 
causative agent, HHV-8 because seroprevaler.ee o f ant- 
HHV-8 antibodies in West Africa was high and quite 
comparable to that seen in the high incidence areas for 
KS. In view o f these findings, it can be hypothesized 
that in sub-Saharan Africa, HHV-8 plays a HIV strain 
selective synergistic role in the pathogenesis o f KS. 
Such a role is illustrated with the HIV-1 strain and not 
HIV-2 strain. The high HHV-8 infection levels already 
prevalent in West Africa are fertile ground for the HI V- 
1 strain and dramatic increases in the incidence o f KS 
more specifically OKS can be anticipated. This point 
calls for further studies from West Africa where HIV-1 
infection has been on the increase and strengthening of 
oral health screening programmes.
O ra l KS by Age.
The high rates o f OKS in the 0 to 4 age group suggest 
that a high proportion o f babies were bom HIV positive 
then developed OKS in infancy as observed in a 
Zimbabwean study o f total body KS.'J At the other end 
o f the age spectrum, the 75+ age group also had high 
OKS rates. The latter increase most likely reflects rates 
o f the endemic form, which usually affects the lower 
extremities of the elderly than the epidemic form o f KS 
or a mixture o f the two. However, at which age group 
the epidemic form ends and the endemic form starts 
remains imprecise. This is further complicated by the 
reported increase o f classic KS in Greece and a 
speculative role o f HHV-8 in this increase.22 This 
study illustrates that OKS is predominantly a disease o f 
young adults, which is attributable to the HIV/AIDS 
epidemic.
O ral KS by Site.
The oral KS frequency o f 51 % in this study represents a 
tenfold increase o f KS frequencies reported in an 
earlier study in Zimbabwe.5 Though the palate is the 
most commonly affected intra-oral site in this study 
and Uganda23 there are'differences in subsequent intra­
oral sites affected by OKS as the Ugandan study had the 
palate followed by the gingiva, tongue and tonsil. 
Ziegler and Katongole-Mbidde (1996) reported a 
similar intra-oral site distribution o f OKS in another 
study from the same geographical region o f east Africa. 
Canto and Devesa (2002) reported that OKS accounted 
for 1.2% mainly occurring on the hard palate and only 
10% o f total KS cases were found in the phaiynx. It can
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be concluded that even though the palate is the most 
commonly affected intra-oral site, differences do occur 
at other intra-oral sites affected by OKS possibly due to 
geographical and or intrinsic factors.
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